March 5, 2018 / 12:41 PM / 9 months ago

BRIEF-FDA Approves PDUFA Fee Waiver For Gimoti New Drug Application

March 5 (Reuters) - Evoke Pharma Inc:

* FDA APPROVES PDUFA FEE WAIVER FOR GIMOTI™ NEW DRUG APPLICATION

* FDA GRANTED ITS REQUEST FOR SMALL BUSINESS WAIVER OF PDUFA FEE OF ABOUT $2.4 MILLION FOR ITS TREATMENT GIMOTI

* COMPANY REMAINS ON TRACK TO FILE GIMOTI NDA NEXT QUARTER

* LOOK FORWARD TO POTENTIAL U.S. PRODUCT LAUNCH IN 2019 OF GIMOTI

* AS CO REVIEWS 2018 BUDGET, ABLE TO EXTEND CASH RUNWAY INTO OCTOBER 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below